Table 1.
UCSF | Mount Sinai | |||||||
---|---|---|---|---|---|---|---|---|
Overall | AD | Control | SMD | Overall | AD | Control | SMD | |
n | 26,412 | 8804 | 17,608 | 17,874 | 5958 | 11,916 | ||
Sex, n (%) | ||||||||
Female | 16,675 (63.1) | 5558 (63.1) | 11,117 (63.1) | <0.001 | 12,584 (70.4) | 4138 (69.5) | 8446 (70.9) | 0.031 |
Male | 9659 (36.6) | 3220 (36.6) | 6439 (36.6) | 5290 (29.6) | 1820 (30.5) | 3470 (29.1) | ||
Unknown | 78 (0.3) | 26 (0.3) | 52 (0.3) | |||||
Estimated age, mean (SD) | 86.5 (6.4) | 86.5 (6.4) | 86.5 (6.4) | <0.001 | 88.6 (10.6) | 88.3 (8.7) | 88.7 (11.4) | −0.039 |
Race, n (%) | ||||||||
American Indian/Alaska Native | 27 (0.1) | 9 (0.1) | 18 (0.1) | <0.001 | 20 (0.1) | 8 (0.1) | 12 (0.1) | 0.129 |
Asian | 2638 (10.3) | 879 (10.3) | 1759 (10.3) | 177 (1.0) | 78 (1.3) | 99 (0.8) | ||
Black/African American | 1758 (6.9) | 586 (6.9) | 1172 (6.9) | 3732 (20.9) | 1214 (20.4) | 2518 (21.1) | ||
Native Hawaiian/Pacific Islander | 1356 (5.3) | 452 (5.3) | 904 (5.3) | 9 (0.1) | 5 (0.1) | 4 (0.0) | ||
Other | 2230 (8.7) | 743 (8.7) | 1487 (8.7) | 3922 (21.9) | 1496 (25.1) | 2426 (20.4) | ||
Unknown | 2017 (7.6) | 673 (7.6) | 1344 (7.6) | 786 (4.4) | 253 (4.2) | 533 (4.5) | ||
White/Caucasian | 16,386 (64.0) | 5462 (64.0) | 10,924 (64.0) | 9228 (51.6) | 2904 (48.7) | 6324 (53.1) | ||
Death status, n (%) | ||||||||
Alive | 20,146 (76.3) | 6714 (76.3) | 13,432 (76.3) | 0.001 | 9371 (52.4) | 3264 (54.8) | 6107 (51.3) | 0.078 |
Deceased | 6266 (23.7) | 2090 (23.7) | 4176 (23.7) | 882 (4.9) | 306 (5.1) | 576 (4.8) | ||
Unknown | 7621 (42.6) | 2388 (40.1) | 5233 (43.9) |
Summary table of sex, estimated age, death status, and first race among Alzheimer’s and control cohorts at UCSF and Mount Sinai. Patients are propensity score-matched at a 1:2 Alzheimer to control ratio with the demographics shown in the table.
SD standard deviation, SMD standardized mean difference.